Glucagon-Like Peptide-1 Receptor Agonists in Polycystic Ovary Syndrome and Women’s Reproductive Health: Metabolic and Reproductive Effects and Preconception Strategies

Reproductive and Developmental Medicine · Published 2026-06-22 · DOI 10.1097/rd9.0000000000000178

Free full text

Authors (10)

Aleksandra Płusa, Simone Szymczyk, Anna Marcinkowska, Julia Nowosielska, Karol Stobiński, Jakub Lech, Natalia Pluta, Patryk Barczuk, Urszula Załuska, Weronika Kopyt

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Płusa, A., Szymczyk, S., Marcinkowska, A., et al. (2026). Glucagon-Like Peptide-1 Receptor Agonists in Polycystic Ovary Syndrome and Women’s Reproductive Health: Metabolic and Reproductive Effects and Preconception Strategies. Reproductive and Developmental Medicine. https://doi.org/10.1097/rd9.0000000000000178

Related articles

• The quality control standards for diagnosis and treatment of polycystic ovary syndrome in Obstetrics and Gynecology Hospital of Fudan University · Reproductive and Developmental Medicine · 2025 · Same journal
• Effect of Jinfeng Pill on ovarian function of Tripterygium wilfordii polyglycoside tablets induced poor ovarian response rats · Reproductive and Developmental Medicine · 2024 · Same journal
• Developing a mouse endometriosis model using stored chocolate cyst slurry: an experimental study · Reproductive and Developmental Medicine · 2025 · Same journal
• Updates on in vitro maturation technology in human immature oocytes for clinical application · Reproductive and Developmental Medicine · 2025 · Same journal
• Exploring the Feasibility of Using Self-Sampling for HPV E6/E7 mRNA Detection in Cervical Cancer Screening Programs · Reproductive and Developmental Medicine · 2026 · Same journal
• Effect of selenium on reproductive function and oxidative stress in male rats with cisplatin-induced testicular damage · Reproductive and Developmental Medicine · 2025 · Same journal
• Understanding lichen sclerosus: pathogenesis and treatment · Reproductive and Developmental Medicine · 2025 · Same journal
• Gut-restricted farnesoid X receptor agonist fexaramine improves abnormal metabolic and reproductive phenotypes in polycystic ovary syndrome model mice · Reproductive and Developmental Medicine · 2026 · Same journal
• Vaginal repair as salvage therapy benefits women with cesarean scar defects after failed repair surgery: a retrospective cohort study · Reproductive and Developmental Medicine · 2025 · Same journal
• Causal effects linking polycystic ovary syndrome and testosterone levels to obstetric outcomes: a two-sample Mendelian randomization study · Reproductive and Developmental Medicine · 2026 · Same journal